Close
Help




JOURNAL

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Pharmacotherapies for COPD

Submit a Paper


Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2013:7 17-34

Review

Published on 25 Apr 2013

DOI: 10.4137/CCRPM.S7211


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Abstract

This review article summarizes the main treatments for chronic obstructive pulmonary disease, their mechanisms, and the key evidence from trials supporting their use. Drug classes covered were short acting beta agonists (SABA), short acting muscarinic antagonists (SAMA), long acting beta agonists (LABA), long acting antimuscarinics (LAMA), inhaled corticosteroids (ICS), LABA/ICS combinations, specific phosphodiesterase (PDE4) inhibitors, non-specific PDE inhibitors, mucolytics, and oxygen. Non-specific therapies, such as opiates for relief of dyspnoea and therapies for smoking cessation, are also covered briefly. For each class of drug, mechanisms of action are described, key clinical trial results are reported, and available agents compared. Finally, the place of each drug in therapy is compared between current worldwide guidelines.



Downloads

PDF  (700.86 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Libertas Academica
This is the first time I have published published an article in Clinical Medicine Insights Case Report.  I was pleased to find that the publishing staff were helpful in guiding my submission and I was impressed by the prompt processing and speed of publication.
Dr Maria Gabriella Gentile (Niguarda Hospital Milan, Italy)
More Testimonials

Quick Links


New article and journal news notification services